NSE filing, NSE: DELAPLEX. Summary written from the filing by ALFA Finder's alert engine.
delaPlex Ltd: key numbers
- Share price
- ₹134.60
- Market cap
- ₹123.3 Cr
- Revenue (annual)
- ₹68.89 Cr
- Net profit (annual)
- ₹12.84 Cr
- P/E (TTM)
- 9.6×Sector 22.9×
- Promoter holding
- 73.86%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from delaPlex Ltd
All →delaPlex Other Announcement
Delaplex Limited declares that the Corporate Governance Report is not applicable to the company, as it is listed on the SME Exchange.
delaPlex Price Movement Clarification
Delaplex Limited clarifies to the exchange that all material information affecting operations has been disclosed, in response to a query on recent share price movement.
delaPlex Acquisition Worth ₹5.04 Cr
Delaplex Limited's subsidiary, Delaplex Software Limited, acquired Bisham Limited and Bisham Consulting Limited for a total consideration not exceeding approximately ₹5.04 Crore.
- Value
- ₹5.04 Cr
delaPlex Annual General Meeting
Delaplex Limited held its 22nd Annual General Meeting on September 12, 2026. The meeting covered routine business, including the adoption of financial statements and director resolutions.
delaPlex Annual General Meeting
Delaplex Limited has scheduled its 22nd Annual General Meeting for September 12, 2026. The meeting will address financial statements, director re-appointments, and managerial remuneration.
delaPlex Other Announcement
Delaplex Limited declared the non-applicability of Corporate Governance compliance for the quarter ended June 30, 2026, due to its listing on the NSE SME platform.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.